Posts

How a timekeeping gene affects tumor growth depends ent...

JANUARY 23, 2024, NEW YORK – A Ludwig Cancer Research study has found that the c...

Study: Stars travel more slowly at Milky Way’s edge

By clocking the speed of stars throughout the Milky Way galaxy, MIT physicists h...

USC Stem Cell study shows how gene activity modulates t...

As people age or become ill, their immune systems can become exhausted and less ...

Locusts’ sense of smell boosted with custom-made nanopa...

Our sensory systems are highly adaptable. A person who cannot see after turning ...

New tool helps predict progression of Alzheimer’s

About 55 million people worldwide are living with dementia, according to the Wor...

EPB, ORNL announce plans for research collaborative foc...

Building on $180 million in joint energy-related research, EPB and Oak Ridge Nat...

Huntsman Cancer Institute receives $20 million land don...

Huntsman Cancer Institute at the University of Utah (the U) has received a $20 m...

Novo Nordisk stakes $255 million to acquire another obe...

Novo Nordisk has signed a partnership with EraCal Therapeutics, a Swiss biotech ...

Gilead’s Trodelvy lung cancer trial fails to increase s...

Gilead encountered a significant setback concerning its antibody-drug conjugate ...

Sanofi snags rare drug INBRX-101 in a bid to pioneer bi...

Sanofi, the prominent pharmaceutical conglomerate, has undertaken a recent merge...

Harnessing the untapped potential of medicines access 

We speak with BAP Pharma to learn more about the challenges and possible benefit...

Evaxion Biotech to develop new vaccines for cancer

Evaxion Biotech has announced plans to develop customised cancer vaccines by tar...

Kyowa Kirin acquires Orchard Therapeutics for $477.6m

Kyowa Kirin has acquired Orchard Therapeutics, a developer of hematopoietic stem...

Synnovation launches with $102m to advance therapy pipe...

Synnovation Therapeutics has launched with a $102m Series A financing to progres...

FDA denies approval for Theratechnologies’ tesamorelin F8

Theratechnologies has received a CRL from the US Food and Drug Administration (F...

PXS-4728 by Syntara for Sleep Disorders: Likelihood of ...

PXS-4728 is under clinical development by Syntara and currently in Phase II for ...